
PIN Pharma: A venture-backed biopharmaceutical firm specializing in immune modulators for diverse health conditions.
Founded with a mission to revolutionize treatment options, PIN Pharma is a venture-backed biopharmaceutical company dedicated to researching and developing immune modulators. Their core focus spans a broad range of indications, including oncology, autoimmunity, and neurodegeneration. By leveraging cutting-edge science, PIN Pharma aims to create innovative therapies that enhance the body's immune response to various diseases, thereby improving patient outcomes and quality of life.
Notable figures associated with PIN Pharma include leading scientists and experienced industry professionals who bring a wealth of knowledge to the company. The firm has attracted significant investment from prominent venture capitalists, underscoring confidence in its potential. Key achievements include successful preclinical trials and promising early-stage clinical results, positioning PIN Pharma as a rising star in the biopharmaceutical industry. Their work has the potential to make a substantial impact on the treatment landscape for several challenging health conditions.

PineTree Therapeutics
pinetreetx.com

IpiNovyx Bio

Rectify Pharmaceuticals
rectifypharma.com

Pharmos
pharmoscorp.com

Reset Pharmaceuticals

Camino Pharma
caminopharma.com

PleoPharma
pleopharma.com

Serpin Pharma
serpinpharma.com

Pinpoint Pharma
pinpointpharma.co

Novita Pharmaceuticals
novita-pharm.com

Peak Bio
peak-bio.com

Phanes Therapeutics
phanesthera.com

Navitor Pharmaceuticals

BioHealthonomics

Kinnear Pharmaceuticals
kinnearpharma.com
Companies similar to PIN Pharma include PineTree Therapeutics, IpiNovyx Bio, Rectify Pharmaceuticals and Pharmos.
PIN Pharma was founded in 2011.
PIN Pharma's headquarters is located in New York City, NY, US.
PIN Pharma's most recent funding round was for $6.8M (USD) in January 2014.
As of Jan 1, 2014, PIN Pharma has raised a total of $6.8M (USD).
PIN Pharma has 1 employee as of Feb 4, 2024.